China tells state firms to halt purchases of major U.S. farm products: sources
China has told state-owned firms to halt purchases of soybeans and pork from the United States, two people familiar with the matter said, after Washington said it would eliminate special treatment for Hong Kong to punish Beijing.
Stock futures steady amid U.S. protests, simmering China tensions
Futures tracking the S&P 500 index were trading flat on Monday following a strong showing in May, as investors turned cautious after protests erupted across the country over race, and simmering tensions between Washington and Beijing heated up.
Eli Lilly starts human study of potential COVID-19 antibody treatment
Eli Lilly and Co said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world’s first study of an antibody treatment against the disease.
Facebook’s Zuckerberg faces employee blowback over ruling on Trump comments
Facebook employees critical of CEO Mark Zuckerberg’s decision not to remove an inflammatory comment from U.S. President Donald Trump took their dissent public over the weekend on Twitter, praising the rival social media firm for taking action and rebuking their own employer.
Zynga to buy Turkish mobile game-maker Peak for $1.8 billion
Zynga Inc said on Monday it would buy Turkish mobile-game maker Peak for $1.8 billion, in a move that will boost the company’s daily active user base by 60%.
Oil steady as OPEC+ considers extension to output curbs
Oil prices were steady on Monday helped by reports that OPEC and Russia were closer to a deal on extending oil cuts but held back by renewed tension between the United States and China.
Walmart’s Flipkart to re-apply for food retail license in India
Walmart Inc’s Indian e-commerce unit Flipkart said on Monday it would re-apply for a food retail license in India after reports said its earlier proposal was rejected by the government last week.
Gilead trades that made millions on COVID-19 drug news raise eyebrows
Well-timed trades in Gilead Sciences Inc’s options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts said.
Coty appoints Chairman Peter Harf as CEO
Cosmetics maker Coty Inc on Monday appointed its Chairman Peter Harf as the chief executive officer of the company, replacing Pierre Laubies, who stepped down after less than two years in the job.
Brazil’s Embraer loses $292 million as stoppages burn cash
Brazilian planemaker Embraer reported a $292 million first quarter loss on Monday due to a coronavirus crisis sales slump and the impact of a failed deal with Boeing Co .
